Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein

Inventors

Johnston, Christopher • COTTON, Sean

Assignees

Fred Hutchinson Cancer Center • ADA Forsyth Institute Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12180487-B2

Patent

Publication Date

2024-12-31

Expiration Date


Abstract

Embodiments include engineered minicircle-producing bacterium with differential methylation capability, as well as kits and compositions comprising the bacterium. Further described are methods of using of the bacterium for producing differentially methylated minicircle DNA, and for improving transformation efficiency of exogenous DNA in intractable bacteria.

Core Innovation

The invention relates to an engineered, minicircle producing bacterium that uses a parental plasmid comprising a minicircle nucleic acid sequence including an exogenous nucleic acid sequence and a plurality of restriction sites outside of the minicircle nucleic acid sequence. The bacterium is configured such that at least one endogenous methyltransferase comprising at least one of a Dam methyltransferase, a Dem methyltransferase, a HsdM methyltransferase, or a combination thereof is absent or non-functional. As a result, the engineered bacterium has reduced DNA-methylation capability, and the exogenous nucleic acid sequence lacks methylation at a plurality of methylation sites that would be methylated in a reference bacterium of the same species as the engineered bacterium.

A related aspect is producing a minicircle comprising the minicircle nucleic acid sequence in which the minicircle lacks methylation at a plurality of methylation sites that would be methylated in a reference bacterium of the same species as the engineered bacterium. The minicircle is produced from the parental plasmid carried in the engineered bacterium, with methylation reduction driven by absence or non-functionality of the endogenous methyltransferase(s) selected from Dam, Dem, and HsdM.

The disclosed embodiments further include refinement in which the engineered bacterium is specified as Escherichia coli and the methylation sites are described by DNA sequence contexts associated with methyltransferase activity, including CCWGG, GATC, and/or AACN6GTGC. Additional embodiments include incorporating at least one inducible ΦC31 integrase and/or an inducible I-SceI homing endonuclease as part of the engineered bacterium used to generate the minicircle DNA.

Claims Coverage

Two independent claims are identified: an engineered, minicircle producing bacterium and a method of producing a minicircle using that bacterium. Each independent claim centers on reduced DNA-methylation capability by making endogenous Dam/Dem/HsdM methyltransferase(s) absent or non-functional, together with a minicircle/exogenous nucleic acid configured to lack methylation at multiple methylation sites relative to a reference bacterium of the same species. In total, the core inventive coverage includes four main inventive aspects: minicircle production from a parental plasmid, restriction sites located outside the minicircle sequence, engineered methylation deficiency via absent/non-functional methyltransferases, and configuring the exogenous sequence/minicircle to lack specified methylation sites.

Minicircle nucleic acid sequence with exogenous nucleic acid and restriction sites outside

A parental plasmid comprising a minicircle nucleic acid sequence comprising an exogenous nucleic acid sequence and a plurality of restriction sites outside of the minicircle nucleic acid sequence.

Engineered absence or non-functionality of endogenous methyltransferase(s)

At least one endogenous methyltransferase comprising at least one of a Dam methyltransferase, a Dem methyltransferase, a HsdM methyltransferase, or a combination thereof is absent or non-functional in the engineered bacterium, such that the engineered bacterium has reduced DNA-methylation capability.

Exogenous nucleic acid lacking methylation at multiple reference methylation sites

The exogenous nucleic acid sequence lacks methylation at a plurality of methylation cites that would be methylated in a reference bacterium of the same species as the engineered bacterium.

Producing a methylation-deficient minicircle

Producing a minicircle comprising the minicircle nucleic acid sequence, wherein the minicircle lacks methylation at a plurality of methylation sites that would be methylated in a reference bacterium of the same species as the engineered bacterium.

Across both independent claims, the inventive concept is to produce minicircle DNA from a parental plasmid while disabling endogenous Dam/Dem/HsdM methyltransferase activity (absent or non-functional) so that the exogenous nucleic acid sequence and the resulting minicircle lack methylation at multiple methylation sites relative to a reference bacterium of the same species.

Stated Advantages

Improves transformation into genetically intractable bacteria by evading restriction-modification degradation, including Type IV restriction-modification.

Documented Applications

Transformation into genetically intractable bacteria is discussed, including improvement in transformation efficiency into Staphylococcus aureus JE2 using SyngenicDNA and SyMPL/minicircle strategies.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.